Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells (Q24306649)

negative regulation of cell population proliferation

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

1 reference

1 reference

E G Van Meir

1

0 references

P J Polverini

2

0 references

V R Chazin

3

0 references

H J Su Huang

4

0 references

N de Tribolet

5

0 references

W K Cavenee

https://scigraph.springernature.com/pub.10.1038/ng1094-171

6

0 references

language of work or name

English

0 references

publication date

October 1994

0 references

published in

Nature Genetics

0 references

volume

8

0 references

page(s)

171-6

0 references

issue

2

0 references

exact match

0 references

cites work

A genetic model for colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1038/NG1094-171

Mutations in the p53 gene occur in diverse human tumour types

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/NG1094-171

WAF1, a potential mediator of p53 tumor suppression

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/NG1094-171

Cancer. p53, guardian of the genome

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

7 January 2021

Growth and metastasis of tumor in organ culture

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

7 January 2021

Molecular genetics of human cancer predisposition and progression

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

7 January 2021

Clonal expansion of p53 mutant cells is associated with brain tumour progression

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

7 January 2021

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

7 January 2021

The p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

7 January 2021

Identification of p53 as a sequence-specific DNA-binding protein

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

7 January 2021

Wild-type p53 can down-modulate the activity of various promoters

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

7 January 2021

Wild-type p53 activates transcription in vitro

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

7 January 2021

Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

7 January 2021

Suppression of human colorectal carcinoma cell growth by wild-type p53

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

7 January 2021

Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

7 January 2021

p53 functions as a cell cycle control protein in osteosarcomas

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

7 January 2021

Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

7 January 2021

Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

7 January 2021

Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors.

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

7 January 2021

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

7 January 2021

Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

7 January 2021

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

7 January 2021

Adult tissues contain chemo-attractants for vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

7 January 2021

Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene.

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

7 January 2021

Regulators of Angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

7 January 2021

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

7 January 2021

Oncogenic forms of p53 inhibit p53-regulated gene expression

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

7 January 2021

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin

1 reference

https://api.crossref.org/works/10.1038%2FNG1094-171

7 January 2021